114 related articles for article (PubMed ID: 11979350)
1. Prognostic role of serum ACE activity on outcome of type 2 diabetic patients on chronic ambulatory peritoneal dialysis.
Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
Am J Kidney Dis; 2002 May; 39(5):1054-60. PubMed ID: 11979350
[TBL] [Abstract][Full Text] [Related]
2. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme (ACE) activity levels in insulin-independent diabetes mellitus and effect of ACE levels on diabetic patients with nephropathy.
Ustündağ B; Canatan H; Cinkilinç N; Halifeoğlu I; Bahçecioğlu IH
Cell Biochem Funct; 2000 Mar; 18(1):23-8. PubMed ID: 10686580
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
5. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function.
Wang AY; Woo J; Wang M; Sea MM; Sanderson JE; Lui SF; Li PK
Nephrol Dial Transplant; 2005 Feb; 20(2):396-403. PubMed ID: 15187196
[TBL] [Abstract][Full Text] [Related]
6. Predictors of patient survival in continuous ambulatory peritoneal dialysis: 10-year experience in 2 major centers in Tehran.
Hakemi MS; Golbabaei M; Nassiri A; Kayedi M; Hosseini M; Atabak S; Ganji MR; Amini M; Saddadi F; Najafi I
Iran J Kidney Dis; 2010 Jan; 4(1):44-9. PubMed ID: 20081304
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
[TBL] [Abstract][Full Text] [Related]
8. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
[TBL] [Abstract][Full Text] [Related]
9. Effects of gender, Helicobacter pylori and hepatitis B virus serology status on cardiovascular and renal complications in Chinese type 2 diabetic patients with overt nephropathy.
Lo MK; Lee KF; Chan NN; Leung WY; Ko GT; Chan WB; So WY; Ng MC; Ho CS; Tam JS; Lam CW; Tong PC; Chan JC
Diabetes Obes Metab; 2004 May; 6(3):223-30. PubMed ID: 15056131
[TBL] [Abstract][Full Text] [Related]
10. Significant lower VVH7-like immunoreactivity serum level in diabetic patients: evidence for independence from metabolic control and three key enzymes in hemorphin metabolism, cathepsin D, ACE and DPP-IV.
Feron D; Begu-Le Corroller A; Piot JM; Frelicot C; Vialettes B; Fruitier-Arnaudin I
Peptides; 2009 Feb; 30(2):256-61. PubMed ID: 19061927
[TBL] [Abstract][Full Text] [Related]
11. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
Fang W; Oreopoulos DG; Bargman JM
Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
[TBL] [Abstract][Full Text] [Related]
12. Nutritional parameters in diabetic patients on CAPD.
Scanziani R; Dozio B; Bonforte G; Surian M
Adv Perit Dial; 1996; 12():280-3. PubMed ID: 8865919
[TBL] [Abstract][Full Text] [Related]
13. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
14. Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition.
Nikzamir A; Nakhjavani M; Esteghamati A; Rashidi A
Nephrol Dial Transplant; 2008 Apr; 23(4):1274-7. PubMed ID: 17986476
[TBL] [Abstract][Full Text] [Related]
15. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
16. ACE gene polymorphism, left ventricular geometry, and mortality in diabetic patients with end-stage renal disease.
Sakka Y; Babazono T; Sato A; Ujihara N; Iwamoto Y
Diabetes Res Clin Pract; 2004 Apr; 64(1):41-9. PubMed ID: 15036826
[TBL] [Abstract][Full Text] [Related]
17. Renal artery stenosis by three-dimensional magnetic resonance angiography in type 2 diabetics with uncontrolled hypertension and chronic renal insufficiency: prevalence and effect on renal function.
Myers DI; Poole LJ; Imam K; Scheel PJ; Eustace JA
Am J Kidney Dis; 2003 Feb; 41(2):351-9. PubMed ID: 12552496
[TBL] [Abstract][Full Text] [Related]
18. Long-term continuous ambulatory peritoneal dialysis in diabetics.
Balaskas EV; Yuan ZY; Gupta A; Meema HE; Blair G; Bargman J; Oreopoulos DG
Clin Nephrol; 1994 Jul; 42(1):54-62. PubMed ID: 7923968
[TBL] [Abstract][Full Text] [Related]
19. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
[TBL] [Abstract][Full Text] [Related]
20. Elevated cardiac troponin T is associated with increased left ventricular mass index and predicts mortality in continuous ambulatory peritoneal dialysis patients.
Duman D; Tokay S; Toprak A; Duman D; Oktay A; Ozener IC; Unay O
Nephrol Dial Transplant; 2005 May; 20(5):962-7. PubMed ID: 15741207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
